Trial intelligence / Profile preview

IV Plerixafor for Stem Cell Mobilization in Multiple Myeloma

NCT00998049Phase 2Completed

Sponsor
Mayo Clinic
Start
Dec 2009
Primary completion
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of plerixafor in multiple myeloma (MM), sponsored by Mayo Clinic. Started Dec 2009; status: completed.

02

Drugs

plerixafor
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT00998049.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00998049.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call